找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Keratoprostheses and Artificial Corneas; Fundamentals and Sur M. Soledad Cortina,Jose de la Cruz Book 2015 Springer-Verlag Berlin Heidelber

[复制链接]
楼主: 银河
发表于 2025-3-23 13:18:11 | 显示全部楼层
Management of Glaucoma Associated with Boston KPro Type I Implantationsurgery and is associated with poorer postoperative outcomes. Pathophysiologic factors include underlying disease process, synechial angle closure, steroid-response intraocular pressure (IOP) elevation, and possible pupillary block. Frequent monitoring with structural and functional testing measures
发表于 2025-3-23 14:06:27 | 显示全部楼层
Boston KPro Type 1: The Role of the Contact Lensafter surgery is a Kontur© Precision Sphere with a 16.0 mm diameter, 9.8 mm base curve, and plano power. Proper centration of the lens and complete corneal coverage are essential for a proper fit, lens retention, and ocular protection. Over-refraction should be measured at each visit and power chang
发表于 2025-3-23 21:20:18 | 显示全部楼层
Boston KPro Type I: Vitreoretinal Considerations. As the use of KPro increases dramatically, so too does the frequency of posterior segment complications seen by the vitreoretinal surgeon in this patient population, as well as the importance of addressing them expeditiously. Special consideration in diagnostic imaging and surgical planning is req
发表于 2025-3-24 02:02:54 | 显示全部楼层
发表于 2025-3-24 03:35:37 | 显示全部楼层
Keratoprostheses in the Setting of Autoimmune Disorderstions including keratoprostheses. The most challenging of this subset of patients to treat are those with corneal blindness due to autoimmune diseases. Studies have suggested that these patients respond poorly to transplantation due to alterations in corneal tissue at the level of the cellular, micr
发表于 2025-3-24 08:56:46 | 显示全部楼层
发表于 2025-3-24 13:07:43 | 显示全部楼层
José L. Güell MD, PhD,Elena Arrondo,M. Soledad Cortina MD,Jaime Echevarría,Maria V. Gómez-Resa,Oscarular. We establish the correspondence between evidence-based health care and translational effectiveness, which, as defined by AHRQ, represents the utilization of the best available evidence in clinical settings. We discuss the process of evidence-based health care and translational effectiveness in
发表于 2025-3-24 17:11:33 | 显示全部楼层
Ahmad A. Aref MD,Thasarat S. Vajaranant MDcondition (diagnosis) (.., prevalence, sensitivity, specificity) or from monitoring its course (i.e., prognosis) (.., prevalence and relative prevalence in cross-sectional observation studies, incidence in cohort studies, and experimental designs including clinical trials). The process of quantifica
发表于 2025-3-24 21:58:55 | 显示全部楼层
发表于 2025-3-24 23:38:10 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-5 22:06
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表